MindImmune Therapeutics, Inc. — Form D

MindImmune Therapeutics, Inc. of KINGSTON, RI, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-04. The offering totals $8.9M, of which $5.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Tracy SaxtonDirectorKingston, RI
Stevin ZornDirectorKingston, RI
Diane GoodingExecutive OfficerKingston, RI
Robert B NelsonExecutive OfficerKingston, RI
Stevin ZornExecutive OfficerKingston, RI
Isaac StonerDirectorKingston, RI
Isaac StonerExecutive OfficerKingston, RI
Isaac StonerRelated PersonKingston, RI
Reetika BhardwajDirectorKingston, RI
Reetika BhardwajRelated PersonKingston, RI
Christopher O'DonnellDirectorKingston, RI
Christopher O'DonnellRelated PersonKingston, RI
Robert NelsonExecutive OfficerShreveport, LA
Bradley MargusDirectorKingston, RI
Bradley MargusRelated PersonKingston, RI
Robert B NelsonDirectorKingston, RI
Frank S MennitiDirectorKingston, RI
Frank S MennitiExecutive OfficerKingston, RI
Richard G HoranDirectorKingston, RI

Other filings by this issuer (3)

FiledFormOfferingSold
2026-03-05D/A$17.0M$15.2M
2025-12-05D$12.0M$10.2M
2019-11-01D$3.0M$750K

More